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Introduction: Osteoarthritis (OA) is considered to be a multifactorial and polygenic disease and diagnosis is mainly
clinical and radiological. Correlation between radiographic data and clinical status has been reported. However, very
few studies, especially in Caucasian people, describe the association between the Kellgren and Lawrence OA
grading scale (KL) and genetic alterations to better understand OA etiopathogenesis and susceptibility. In order to
update the knee OA grading, in this study we assessed the associations between KL grade, clinical features such as
American Knee Society Score (AKSS), age, and polymorphisms in the principal osteoarthritis susceptibility (OS) genes
in Sicilian individuals.
Methods: In 66 Sicilian individuals affected by primary knee OA, the clinical and radiographic evaluation was
performed using 2 sub-scores of AKSS (knee score (KS) and function score (FS)) and KL. The patients were also
classified according to age. Online Mendelian Inheritance in Man (OMIM) and Database of Single Nucleotide
Polymorphisms (dbSNP) Short Genetic Variations databases were used to select gene regions containing the
following polymorphisms to analyze: FRZB rs288326 and rs7775, MATN3 rs77245812, ASPN D14 repeats, PTHR2
rs76758470, GDF5 rs143383 and DVWA rs11718863. Patient genotypes were obtained using Sanger DNA sequencing
analysis.
Results: In our cohort of patients a statistical association between the variables analyzed was reported in all
associations tested (KL versus KS, FS and age). We observed that a mild to severe OA radiographic grade is related
to severe clinical conditions and loss of articular function and that the severity of symptoms increases with age.
Concerning the genotyping analysis, our results revealed a significant statistical association between KL grading and
GDF5 rs143383 and DVWA rs11718863 genetic alterations. The latter was also associated with a more severe
radiographic grade, displaying its predictive role as OA marker progression. Statistically significant association
between clinical, radiographic and genetic signs observed, suggests extending the actual grading of knee OA
based mainly on X-ray features.
Conclusions: This work represents a multidisciplinary and translational medicine approach to study OA where
clinical, radiological, and OS5 and OS6 SNPs evaluation could contribute to better define grading and progression
of OA and to the development of new therapies.* Correspondence: luigi.minafra@ibfm.cnr.it
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Osteoarthritis (OA) is a multifactorial, inflammatory and
degenerative disorder of the joints [1-5]. OA involves
the synovial tissues and articular cartilage, resulting in
symptoms that cause a decrease in the quality of life and
disability. Among the risk factors, age contributes to a
substantially increased risk of knee OA onset and pro-
gression [6-9], even if the association of age with the
progression of knee OA is sometimes conflicting [10].
OA diagnosis is mainly clinical and radiological, and
X-ray images are the gold standard to confirm the clinical
diagnosis and to grade the disease [11-13]. A critical point
for OA diagnosis is to identify an early onset and an early
progression of this disease. Many studies analyzed the cor-
relation between knee OA radiographic data and clinical
status of the affected joint by using specific clinical scores
and radiographic grading scales. A strong statistical asso-
ciation between pain and the Kellgren and Lawrence
osteoarthritis grading scale (KL) of knee OA was observed
by Muraki and colleagues in an older Japanese population
[14]. Moreover, a study conducted by Cho and colleagues
in a Korean population showed that knee OA symptoms
became more severe with high KL levels and also that KL
values were related to sex: women had worse symptoms
than men at the same radiographic grade [15]. In addition,
Cubukcu and colleagues investigated the possible relation
between KL and the Western Ontario and McMaster
Universities subscore of function, pain and stiffness, but
the association was not often verified [16]. These findings
were in agreement with data reported by recent observa-
tions that knee radiographic OA results cannot always be
related to knee pain, due to radiographic view extension,
definition of pain and variability of the cohort selected for
the studies [17]. The Ahlbäck OA radiographic grading
scale was used by Hernàndez-Vaquero and Fernández-
Carreira in a Spanish study to analyze the relation of OA
with clinical status expressed by the Hospital for Special
Surgery Knee Score. However, a small variation of the
clinical status score compared with the radiographic
grades was observed [18].
Nowadays, molecular genetic investigations have gained
an increasingly significant role in the knowledge of OA
etiology and have provided evidence for a genetic compo-
nent to OA [19-21]. The completion of large genome-wide
association studies introduced single nucleotide polymor-
phisms (SNPs) as risk factors for human disease. Several
gene association analyses, either genome wide or a gene
candidate approach, identified different genes related to
the OA susceptibility, onset and progression. OA may thus
be placed into the category of polygenic diseases [22-24],
but the functional influence of specific SNPs on OA needs
further research in order to contribute to the etiopatho-
genesis. Several association studies between SNPs and OA
disease remain unconfirmed or controversial, due to biasin patient enrolling criteria, differences in OA-affected
joint sites, in classification and staging modes, in the radio-
graphic evaluation scales used and in subjective differences
in patient’s pain evaluation scoring. Furthermore, it be-
comes of interest to explore the geographical and ethnic
allele distribution, which is extremely important in fully
understanding the SNP variant effects. Precisely, Sicilian
individuals have a specific genetic background and differ-
ent allele distribution compared with the rest of Europe
and with the rest of Italy (north–south genetic trend), due
to distinct gene–environment interactions and, certainly,
due to deep human migration movements, which have oc-
curred in Sicily over the centuries as described by several
authors [25-28].
For all these reasons and the lack of comparison with
studies conducted on Italian cohorts, we have chosen to
initiate this study on our cohort of Sicilian OA patients
starting from loci listed and described by the Online
Mendelian Inheritance in Man database, widely recog-
nized as a comprehensive and authoritative compendium
of human genes and genetic phenotypes.
Particularly, in the Online Mendelian Inheritance in
Man database – which collects known genetic lesions
responsible for human inherited diseases – the following
principal loci of osteoarthritis susceptibility (OS) and the
associated polymorphisms, SNPs and aspartic acid (D)
repeats, are reported: frizzled-related protein (FRZB)
rs288326 (OS1A) and rs7775 (OS1B), MATN3 rs77245812
(OS2), ASPN D14 repeats (OS3), parathyroid hormone 2
(PTHR2) rs76758470 (OS4), growth and differentiation
factor 5 (GDF5) rs143383 (OS5) and DVWA rs11718863
(OS6).
In particular, the FRZB gene is a member of a family of
the soluble Wingless (Wnt) antagonist. Recent evidence
has demonstrated that products of Wnt and Frizzled play
a key role in the development and maintenance of bones
and joints [29,30]. The rs7775 and rs288326 FRZB SNPs
variants showed an increased frequency in subjects with
generalized radiographic OA, as confirmed by other stu-
dies in Caucasian individuals [31,32].
Articular cartilage is composed of specialized cells, the
chondrocytes, that produce a large amount of extracellular
matrix composed of collagen fibers. MATN3 encodes
a noncollagenous extracellular matrix protein expressed
during the development of the skeletal system and in the
cartilage [33]. Another extracellular matrix component
deregulated in the articular cartilage of OA patients is
asporin protein, encoded by the ASPN gene and expressed
at high levels in knee and hip cartilage of individuals with
ASPN D14 repeats [34]. The PTHR2 receptor is a mem-
ber of the G-protein coupled receptor family 2 and its
functional role in OA is based on the observation that
PTHR2 is expressed in a number of endocrine cell types
and regulates pituitary hormone secretion and specifically
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ment and maintenance of bone and cartilage has also been
recognized. Mutations in GDF5 are involved in several
disorders of skeletal development and also in hip and knee
OA progression [35-37]. Finally, the DVWA gene, which
encodes for a protein containing two von Willebrand A
domains, was found to harbor the rs11718863 SNP, sho-
wing a consistent association with knee OA in Japanese
and Chinese OA cohorts [38].
Although several studies described the association bet-
ween these specific polymorphisms and susceptibility to
OA, to our knowledge no studies have examined their
simultaneous presence in OA patients, especially in the
European people groups. The purpose of this pilot study
is to highlight possible associations between KL grade,
clinical features (American Knee Society Score (AKSS),
age) and the abovementioned genetic polymorphisms in
order to update the knee OA grading and to improve a
personalized treatment program in the future.Methods
Patients
On admission to hospital, 66 Sicilian patients affected by
primary OA, aged 54 to 86 years and candidates
for knee surgery of arthroscopy or arthroplasty, were en-
rolled in this project. The patients were grouped, ac-
cording to age, into two groups: young (from 54 to
65 years old) and old (from 66 to 86 years old). Among
these, 61 patients were selected for genotyping analysis
due to availability of a blood sample. This study (named
OA_BIOMOL_1) was approved by the Ethical Commit-
tee of the San Raffaele G. Giglio Hospital, Cefalù, Italy
(number of protocol: CE 2011/63) and the patients gave
their written informed consent according to the Helsinki
Declaration.Clinical evaluation
The clinical evaluation was performed for each patient
before surgery using the AKSS, which includes two sub-
scores: knee score (KS) and function score (FS). Each
subscore ranges from 0 to 100 points. For KS evaluation,
pain, range of motion, anterior–posterior and medio-
lateral stability, flexion contracture, leg extension and
varus–valgus alignment were investigated. FS evaluates
knee function from a patient’s point of view, describing
walking ability, climbing stairs ability and the use of
walking aids. The AKSS was classified into three levels
for both KS and FS: high (HKS, HFS), medium (MKS,
MFS) and low (LKS, LFS).
The patients with LKS and LFS had scores between 0
and 49 points. The patients with MKS and MFS had
scores between 50 and 69 points. The patients with HKS
and HFS had scores from 70 to 100.Radiographic evaluation
The radiographic evaluation was performed on antero-
posterior and lateral X-ray views of the knee by a single
investigator using the KL, which includes four grades:
grade 1, possible narrowing of joint space and possible
presence of osteophytes; grade 2, definite narrowing of
joint space and definite osteophytes; grade 3, definite nar-
rowing of joint space, multiple osteophytes, sclerosis, cysts
and possible deformity of bone contour; and grade 4,
marked narrowing of joint space, large osteophytes, severe
sclerosis, cysts and definite deformity of bone contour
[39,40]. The evaluation was undertaken on an X-ray per-
formed no more than 4 months before surgery. In our
study we grouped grade 1 and grade 2 into a single grade
because the radiographic differences in our cohort were
considered not relevant compared with those between KL
grade 3 and grade 4. The KL classification was therefore
summarized into three groups: group A (grades 1 and 2),
group B (grade 3), and group C (grade 4).
Genetic analysis
The patients were genotyped by sequencing analysis, for
the following genetic polymorphisms associated with OS,
SNPs and D repeats: FRZB rs288326 (OS1A) and rs7775
(OS1B), MATN3 rs77245812 (OS2), PTHR2 rs76758470
(OS3), ASPN D14 repeats (OS4), GDF5 rs143383 (OS5)
and DVWA rs11718863 (OS6). The Human Gene Muta-
tion Database [41] and the dbSNP Short Genetic Varia-
tions database [42] were used to analyze gene regions
containing the selected SNPs. Genomic DNA was ex-
tracted from peripheral blood using the QIAamp DNA
blood mini kit, according to the manufacturer’s specifica-
tions (Qiagen Inc., Valencia, CA, USA).
After quality and quantity analysis, DNA was polyme-
rase chain reaction amplified using primers designed by
the Primer3 software [43] and listed in Table 1. Polymerase
chain reaction reactions were performed with 50 ng gen-
omic DNA in a total volume of 50 μl containing 1× PCR
Gold Buffer, 1.5 mM di-MgCl2, 200 μM dNTPs, 200 nM
forward and reverse primer mix and 1.25 U AmpliTaq
Gold DNA Polymerase (Life Technologies Monza, MB,
Italy). The thermal cycle profile employed a 5-minute
denaturing step at 94°C, followed by 35 cycles at 94°C for
45 seconds, 59°C for 45 seconds and 72°C for 45 seconds,
and a final extension step of 5 minutes at 72°C. The quality
and quantity of polymerase chain reaction products were
assessed on the Bioanalyzer instrument (Agilent Technolo-
gies, Santa Clara, CA, USA) and were purified using the
QIAquick PCR purification kit, according to the manufac-
turer’s specifications (Qiagen Inc., Valencia, CA, USA).
To perform DNA sequencing, purified amplicons were
labeled with the BigDye Terminator v3.1 Cycle Sequen-
cing Kit following the manufacturer’s standard protocol
(Applied Biosystems). The thermal cycle profile employed
Table 1 Primers sequence used for genotyping analysis
Target gene polymorphism Forward primer (5′ to 3′) Reverse primer (5′ to 3′) Template size (base pairs)
FRZB (rs288326; OS1A) cctcttggcagcaattggaac gcccctctcccaagaaaaatg 800
FRZB (rs7775; OS1B) agggcaggaccttgtctgtt taagagtctgcccccaaacc 884
MATN3 (rs77245812; OS2) tcacgtcacttcaggctgtg tggggtctcaccatgttctc 886
ASPN (D14; OS3) gcacattgctgaattgctttcca ctttggggtttgctgtactttc 615
PTH2R (rs144641723; OS4) tctcgaaccagtccctgct cccatgacagttgctgtgg 602
GDF5 (rs143383; OS5) gcagatgaattccaggtccag ccatgaggtggaggtgaaga 818
DVWA (rs11718863; OS6A) aggctgcctgccattattctt cccatgctgtttcctttgaaca 924
FRZB, frizzled-related protein; MATN3, matrilin 3; aspn, asporin; D, aspartic acid repeat; PTHR2, parathyroid hormone 2; GDF5, growth and differentiation factor 5;
DVWA, double von Willebrand A.
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at 96°C for 10 seconds, 54°C for 5 seconds and 60°C for
3 minutes. Labeled samples were purified with the X-
terminator purification kit according to the manufacturer’s
standard protocol and loaded in a 3500-Dx Genetic
Analyzer (Applied Biosystems) for separation by capillary
electrophoresis. Electropherograms and sequence files
were analyzed using Sequencing Analysis and SeqScape
software (Applied Biosystems).
Statistical analysis
The association between the clinical data (KS, FS, age)
and the radiographic data (KL) and the association bet-
ween genotypes and KL groups (A, B, C) were analyzed
using GraphPad InStat software version 3.05 [44]. The
Mann–Whitney U test, the chi-square test and Fisher’s
exact test were performed. Differences in groups were
considered significant when P ≤ 0.05. Hardy–Weinberg
equilibrium was evaluated as described previously [28].
Results
Clinical and radiographic evaluation
We recruited 66 cases (37 females and 29 males), of which
24 were young (54 to 65 years) and 42 were old (66–86
years), and they were divided into three groups (A, B, C)
depending on the degree of radiographic knee OA.
According to the clinical scores we classified the patients
as follows. Group A consisted of 24 patients (11 females
and 13 males, 14 young and 10 old); KS was poor in 13
cases and fair in 11 cases, and the average FS score was 51
points. Group B consisted of 21 patients (15 females and
six males, eight young and 13 old); KS was poor in 19 cases
and fair in two cases, and the average FS score was 41Table 2 Clinical features and treatment for each radiographic
KL group Total Females Males Y
A 24 (36.5%) 11 (29.7%) 13 (44.8%) 14
B 21 (31.8%) 15 (40.5%) 6 (20.7%) 8
C 21 (31.8%) 11 (29.7%) 10 (34.5%) 2
Data presented as number of patients (percentage). KL, Kellgren and Lawrence ostepoints. Group C consisted of 21 patients (11 females and
10 males, two young and 19 old); KS was low in all cases,
and the average FS was 35 points.
Regarding the treatment, 22 patients of group A
underwent arthroscopy and two patients arthroplasty,
two patients of group B underwent arthroscopy and 19
patients arthroplasty, and 21 patients of group C under-
went arthroplasty (Table 2).
According to the KS and FS scores, the patients in the
LKS group were in the majority (n = 46), while the 36 pa-
tients in the LFS group generally had severe symptoms
and high disability. There were 19 patients in the MKS
group and 23 patients in the MFS group, and thus one-
third of patients had moderate to severe symptoms and
disability. One patient was in the HKS group and seven
patients were in the HFS group, with zero to mild symp-
toms and disability (Table 3).Association between Kellgren and Lawrence osteoarthritis
grading and knee score, function score and age
Association analyses were performed to verify the pos-
sible association between clinical data (KS, FS, age) and
radiographic data (KL). A statistical association between
the variables analyzed was observed (Table 4).Kellgren and Lawrence osteoarthritis grading versus knee score
In group A, we observed eight patients (33.3%) with LKS,
15 (62.5%) with MKS and one (4.2%) with HKS. In group
B, we observed 17 patients (81%) with LKS, four (19%)
with MKS and none with HKS. In group C, we observed
all patients (n = 21) with LKS. The highest number of pa-
tients with LKS were therefore in groups B and C andgroup of patients
oung Old Arthroscopies Arthroplasties
(58.3%) 10 (23.8%) 22 (91.7%) 2 (4.8%)
(33.3%) 13 (30.0%) 2 (8.3%) 19 (45.2%)
(8.3%) 19 (45.2%) 0 21 (50%)
oarthritis grading scale.
Table 3 Patient classification according to knee score and
function score
KS group n % FS group n %
LKS 46 70 LFS 36 55
MKS 19 29 MFS 23 35
HKS 1 2 HFS 7 11
FS, function score (LFS, low; MFS, medium; HFS, high); KS, knee score (LKS, low;
MKS, medium; HKS, high); n, number of patients.
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expressed by the KS score (P = 0.0001).
Kellgren and Lawrence osteoarthritis grading versus
function score
In group A, we observed eight patients (33.3%) with LKS,
10 (41.7%) with MFS and six (25%) with HFS. In group B,
we observed 13 patients (62%) with LFS, seven (33.3%)
with MFS and one (4.7%) with HFS. In group C, we ob-
served 15 patients (71.4%) with LFS, six (28.6%) with MFS
and none with HFS. These data show that an increase of
the OA radiographic severity corresponds to a decrease
of the function score (P = 0.022).
Kellgren and Lawrence osteoarthritis grading versus age
In group A, we observed 14 young (58.3%) and 10 old
(41.7%) patients. In group B, we observed eight young
(38.1%) and 13 old (61.9%) patients. In group C, we ob-
served two young (9.5%) and 19 old (90.5%) patients. So,
it is more common to observe a medium to high OA
radiographic grade in the population over 65 years old,
and a low to medium in adults under the age of 65 years
old (P = 0.0011).
Mutational analysis of osteoarthritis susceptibility genes
The OA patients were genotyped for the following poly-
morphisms associated with OS, such as SNPs and DTable 4 Association between Kellgren and Lawrence
osteoarthritis grading and knee score, function score
and age
KL score
Group A Group B Group C P valuea
n % n % n %
Low knee score 8 33.3 17 81 21 100 <0.0001
Medium knee score 15 62.5 4 19 0 0
High knee score 1 4.2 0 0 0 0
Low function score 8 33.3 13 62 15 71.4 0.022
Medium function score 10 41.7 7 33.3 6 28.6
High function score 6 25 1 4.7 0 0
Age 54 to 65 14 58.3 8 38.1 2 9.5 0.0011
Age 66 to 86 10 41.7 13 61.9 19 90.5
KL, Kellgren and Lawrence osteoarthritis grading scale; n, number of patients.
aChi-squared test.repeats: FRZB rs288326 and rs7775, MATN3 rs77245812,
ASPN D14, PTHR2 rs76758470, GDF5 rs143383, and
DVWA rs11718863. Percentages of the wild type, hetero-
zygote and homozygote genotypes for each polymorphism
were calculated. We reported genotyping data of the
three radiographic groups (A, B, C) and the number of
individuals for each genotype (Table 5). In each group, de-
viations of Hardy–Weinberg equilibrium for all polymor-
phisms analyzed were not observed.
Kellgren and Lawrence osteoarthritis grading and
genotype association analysis
To evaluate a potential association between genotypes,
wild-type group or mutated (heterozygote and homozy-
gote) group and the KL groups (A, B, C), the Mann–
Whitney U test, the chi-square test and Fisher’s exact test
were performed (Table 6). Analysis showed a statistically
significant association between genotype and KL grade for
the GDF5 rs143383 and the DVWA rs11718863 polymor-
phisms (P = 0.02 and P = 0.03, respectively). These results
are in line with the study of Valdes and colleagues where
GDF5 rs143383 and DVWA rs11718863 polymorphisms
are consistently associated with the risk of knee OA in the
Caucasian population [45], but to our knowledge this is
the first study that reports the simultaneous presence
of these two polymorphisms associated with KL in a
European group. Unfortunately, concerning the other four
OS SNPs, no genotype showed any significant association
with KL data, as revealed by statistical analysis.
Finally, it is possible to note in Table 6 that the
DVWA rs11718863 polymorphism (genotype hetero-
zygote + homozygote) is more represented in group C
(55%), compared with the other two groups A (25%) and
B (19%), suggesting that OS6 can be associated with a
more severe OA radiographic grade.
Discussion
OA grading is commonly based on the radiographic clas-
sification of Kellgren and Lawrence [39] and can be sup-
ported by general or joint specific clinical and functional
scores (for example, Western Ontario and McMaster
Universities score, AKSS, and so forth) [46].
The aim of our pilot study was to update the knee OA
grading with further clinical and genetic associated data,
since OA is nowadays considered a polygenic and multi-
factorial disease [47].
We investigated the possible association between KL
grade, clinical features (AKSS, age) and susceptibility poly-
morphisms to OA, such as FRZB (OS1A and OS1B),
MATN3 (OS2), PTHR2 (OS3), ASPN D14 (OS4), GDF5
(OS5) and DVWA (OS6), in order to better define the
grading of this disorder. As far as we know, this is the first
study that simultaneously evaluates the association bet-
ween clinical and radiographic data and the presence of
Table 5 Genetic analysis results
Polymorphism Genotype Group A (n = 20) % HWe P value Group B (n = 21) % HWe P value Group C (n = 21) % HWe P value
FRZB (rs288326; OS1A)
CC WT 17 85 0.05 14 66.7 0.36 15 75 0.33
CT H 2 10 7 33.3 4 20
TT MUT 1 5 0 0 1 5
FRZB (rs7775; OS1B)
CC WT 18 90 0.03 16 76.2 0.54 13 65 0.34
CG H 2 10 5 23.8 7 35
GG MUT 0 0 0 0 0 0
MATN3 (rs77245812; OS2)
CC WT 19 95 0.91 20 95.2 0.91 18 90 0.81
CT H 1 5 1 4.8 2 10
TT MUT 0 0 0 0 0 0
ASPN (D14; OS3)
D13 WT 5 25 0.65 3 14.3 0.12 4 20 0.65
D13/D14 H 11 55 14 66.7 11 55
D14 MUT 4 20 4 19 5 25
PTH2R (rs144641723; OS4)
GG WT 19 95 0.91 21 100 NA 20 100 NA
GT H 1 5 0 0 0 0
TT MUT 0 0 0 0 0 0
GDF5 (rs143383; OS5)
TT WT 3 15 0.18 12 57.1 0.04 7 35 0.44
TC H 13 65 5 23.8 11 55
CC MUT 4 20 4 19 2 10
DVWA (rs11718863; OS6)
TT WT 15 75 0.33 17 81 0.63 9 45 0.39
TA H 4 20 4 19 10 50
AA MUT 1 5 0 0 1 5
D, aspartic acid repeat; FRZB, frizzled-related protein; GDF5, growth and differentiation factor 5; H, heterozygote; HWe, Hardy–Weinberg equilibrium; MUT, homozygote; NA, not available; OS, osteoarthritis susceptibility;
















Table 6 Association between Kellgren and Lawrence
osteoarthritis grading and genotype
Polymorphism KL group WT H +Mut P valuea
n % n %
A 17 85 3 15 0.39
FRZB-OS1A (rs288326) B 14 66.7 7 33.3
C 15 75 5 25
A 18 90 2 10 0.17
FRZB-OS1B (rs7775) B 16 76.2 5 23.8
C 13 65 7 35
A 19 95 1 5 0.75
MATN3-OS2 (rs77245812) B 20 95.2 1 4.8
C 18 90 2 10
A 5 25 15 75 0.69
ASPN-OS3 (D14) B 3 14.3 18 85.7
C 4 20 16 80
A 19 95 1 5 NA
PTH2R-OS4 (rs144641723) B 21 100 0 0
C 20 100 0 0
A 3 15 17 85 0.02
GDF5-OS5 (rs143383) B 12 57.1 9 42.9
C 7 35 13 65
A 15 75 5 25 0.03
DWVA-OS6 (rs11718863) B 17 81 4 19
C 9 45 11 55
D, aspartic acid repeat; FRZB, frizzled-related protein; GDF5, growth and
differentiation factor 5; H, heterozygote; KL, Kellgren and Lawrence osteoarthritis
grading scale; MUT, homozygote; n, number of patients; NA, not available; OS,
osteoarthritis susceptibility; PTHR2, parathyroid hormone 2; WT, wild type.
aChi-squared test.
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In our cohort of 66 patients, a statistical association
between the variables analyzed was observed (KL data
versus: KS, FS, age). In particular, statistical association
between KL grade versus KS and FS showed that KL
group A can be associated with a medium clinical score,
while KL group B and KL group C are related with low
KS and FS. This suggests that a mild to severe OA radio-
graphic grade is linked to severe clinical conditions and
loss of articular function. In addition, association ana-
lysis between KL grade and age of patients confirms that
severity of symptoms increases with age: the majority of
our patients with KL grade A were 54 to 65 years old,
and most of the patients with grade C were 65 to
86 years old.
Concerning the mutational analysis, we genotyped the
patients for the abovementioned OS SNPs and our results
revealed a significant statistical association between KL
grade and GDF5 rs143383 (OS5) and DVWA rs11718863(OS6) genetic alterations. The presence of these SNPs
could thus contribute to better define OA grading and
progression.
As described by several authors, the OS5 rs143383
SNP is still the most robustly replicated polymorphism
associated with OA and the only locus successfully
validated across diverse Asian and European popula-
tions. The OS5 rs143383 polymorphism, localized in the
5′-untranslated region, causes a decrease in the tran-
scriptional activity of GDF5. This gene, expressed in the
adult human articular cartilage, encodes growth differen-
tiation factor 5, a bone morphogenic protein involved in
the development, homeostasis and repairing of the bone,
cartilage and other articular tissues [48].
To our knowledge, genetic contribution to radiographic
severity in knee OA was previously described only by
Valdes and colleagues in the UK OA patients and no in-
formation is available on individuals from other European
countries. For the first time, our work analyzes the asso-
ciation between KL grade, clinical features (AKSS, age)
and the rs143383 GDF5 SNP in Sicilian OA patients. In
order to support this variant role as a progression marker
in knee OA, we meta-analyzed our results with those pre-
viously published by Valdes and colleagues [49]. Nonethe-
less, the UK OA cohorts are much larger than our Sicilian
cohort but all the populations are comparable for age and
body mass index, whereas a slight reduction of the
rs143383 T-allele percentage is observable in Sicilian cases
with respect to the other UK populations (data not
shown). Overall, the Sicilian OA patients’ odds ratio of
1.53 (confidence interval, 1.11 to 2.11) describes a positive
association between rs143383 GDF5 and KL (KL ≤ 2 vs.
KL > 2), a trend in line with Valdes and colleagues [48],
supporting this variant as an OA progression marker.
The OS6 rs11718863 polymorphism is localized in an
exonic region of the DWVA gene and causes a missense
mutation with a consequent amino acidic substitution
Tyr169Asn [50]. The DWVA protein, involved in cellular
adhesion and protein to protein interactions, interacts
with β-tubulin of microtubules and has an important role
in the regulation of chondrocyte differentiation, protecting
articulate joints from OA onset. In particular, the OS6
rs11718863 SNP induces a decreasing interaction between
DVWA and β-tubulin [51,52]. The DVWA rs11718863
SNP is reported to be strongly associated with the risk of
knee OA (odds ratio = 1.43, P < 7 × 10−11) and able to in-
fluence β-tubulin binding in Asian populations. Never-
theless, Valdes and colleagues showed an association
between this genetic alteration and knee OA in the UK
Nottingham total knee replacement OA group (P < 0.046)
[32]. Meulenbelt and colleagues also described a mode-
rately significant association in the UK sample (P = 0.046),
not confirmed for other European countries. However, the
higher risk allele frequency in the European samples
Figure 1 Model of relationship between Kellgren and Lawrence osteoarthritis grading scale groups and clinical and genetic factors
described in our study. FS, function score; KS, knee score; OA, osteoarthritis; OS, osteoarthritis susceptibility; SNP, single nucleotide polymorphism.
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and, once again, the need to evaluate the alleles’ geo-
graphic distribution [38].
In addition, in our cohort of patients this genetic alteration
was more represented in the KL group C (55%) compared
with the other groups, KL group A (25%) and KL group B
(19%), respectively. We therefore suggest that OS6 can be as-
sociated with a more severe OA radiographic grade, display-
ing its predictive role as OA marker progression.
In summary, according to our results we propose a
model where we highlight the relationship between all
data obtained, clinical and radiographic groups, and gen-
etic factors. Our data pointed out that patients who be-
long to the KL group A (affected by mild OA) are younger
and show a better joint function. In contrast, patients be-
longing to KL group B have a gradual progression of the
disease. Finally, patients of KL group C have a more severe
OA, they are older, they have poor function of the joint
and most of them carry the rs11718863 OS6 polymor-
phism. Furthermore, according to our evidence, we show
the DNA contribution, represented by rs143383 GDF5
and rs11718863 DVWA SNPs in defining the KL grade in
OA prognosis and progression (Figure 1).Conclusion
The statistically significant association between clinical,
radiographic and genetic signs observed suggests the ex-
tension of the actual grading of knee OA based mainly
on X-ray features.
This work highlights the importance of a multidiscipli-
nary and translational medicine approach to study OA
where clinical, radiological, and OS5 and OS6 SNP ana-
lysis could contribute to better define grading and pro-
gression of OA and to the development of new therapies.
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